Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,5345 USD | +0,47% | +0,47% | +95,79% |
Attività
Numero di dipendenti: 29
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 01/07/07 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 23/12/12 |
Chief Tech/Sci/R&D Officer | - | 12/05/22 | |
Bob Dagher
CTO | Chief Tech/Sci/R&D Officer | 55 | 17/07/23 |
Yael Gothelf
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/07 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 01/06/20 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/06/14 |
General Counsel | - | 12/05/22 | |
Mary Kay Turner
LAW | General Counsel | - | 07/08/17 |
Yossef Levy
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 22/09/00 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/06/14 |
Jacob Frenkel
CHM | Chairman | 81 | 30/03/20 |
Director/Board Member | 63 | 28/10/21 | |
Director/Board Member | 61 | 05/02/18 | |
Stacy Lindborg
BRD | Director/Board Member | 53 | 01/06/20 |
Nir Naor
BRD | Director/Board Member | 50 | 20/06/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 68 341 857 | 59 284 308 ( 86,75 %) | 0 | 86,75 % |
Coordinate società
Brainstorm Cell Therapeutics, Inc.
1325 Avenue of Americas 28th floor
10019, New York
+201 488 0460
http://www.brainstorm-cell.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+95,79% | 36,53 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione BCLI
- Società Brainstorm Cell Therapeutics Inc.